Phase I and pharmacological study of the pulmonary cytotoxin 4-ipomeanol on a single dose schedule in lung cancer patients: hepatotoxicity is dose limiting in humans.
暂无分享,去创建一个
E K Fishman | E K Rowinsky | D. Ettinger | E. Fishman | M. Christian | D. Noe | R. Donehower | E. Rowinsky | B. Lubejko | D S Ettinger | D A Noe | M C Christian | B G Lubejko | S E Sartorius | M R Boyd | R C Donehower | S. Sartorius | M. Boyd
[1] M. Boyd,et al. Metabolic activation of 4-ipomeanol in human lung, primary pulmonary carcinomas, and established human pulmonary carcinoma cell lines. , 1990, Journal of the National Cancer Institute.
[2] M. Boyd,et al. Renal toxicity due to reactive metabolites formed in situ in the kidney: investigations with 4-ipomeanol in the mouse. , 1981, The Journal of pharmacology and experimental therapeutics.
[3] M. Boyd. Evidence for the Clara cell as a site of cytochrome P450-dependent mixed-function oxidase activity in lung , 1977, Nature.
[4] M. Boyd,et al. Preclinical toxicology studies of 4-ipomeanol: a novel candidate for clinical evaluation in lung cancer. , 1987, Cancer treatment reports.
[5] M. Boyd. Effects of inducers and inhibitors on drug-metabolizing enzymes and on drug toxicity in extrahepatic tissues. , 2008, Ciba Foundation symposium.
[6] M. Boyd,et al. In vitro metabolic activation of the pulmonary toxin, 4-ipomeanol, in nonciliated bronchiolar epithelial (Clara) and alveolar type II cells isolated from rabbit lung. , 1982, The Journal of pharmacology and experimental therapeutics.
[7] M. Boyd,et al. Effects of anti-NADPH-cytochrome c reductase and anti-cytochrome b5 antibodies on the hepatic and pulmonary microsomal metabolism and covalent binding of the pulmonary toxin 4-ipomeanol. , 1978, Biochemical and biophysical research communications.
[8] M. Boyd,et al. Metabolic activation and cytotoxicity of 4-ipomeanol in human non-small cell lung cancer lines. , 1986, Cancer research.
[9] M. Boyd,et al. Confirmation by chemical synthesis of the structure of 4-ipomeanol, a lung-toxic metabolite of the sweet potato, Ipomoea batatas. , 1972, Nature: New biology.
[10] M. Boyd,et al. Pulmonary endothelial and bronchiolar epithelial lesions induced by 4-ipomeanol in mice. , 1985, The American journal of pathology.
[11] M. Boyd,et al. Distribution and metabolism of the pulmonary alkylating agent and cytotoxin, 4-ipomeanol, in control and diethylmaleate-treated rats. , 1982, Biochemical pharmacology.
[12] M. Boyd,et al. Distribution, excretion, and binding of radioactivity in the rat after intraperitoneal administration of the lung-toxic furan, [14C]4-Ipomeanol. , 1975, Toxicology and applied pharmacology.
[13] M. Boyd,et al. Comparison of ratios of covalent binding to total metabolism of the pulmonary toxin, 4-ipomeanol, in vitro in pulmonary and hepatic microsomes, and the effects of pretreatments with phenobarbital or 3-methylcholanthrene. , 1980, Biochemical and biophysical research communications.
[14] M. Boyd,et al. METABOLIC ACTIVATION AS A BASIS FOR ORGAN‐SELECTIVE TOXICITY , 1983, Clinical and experimental pharmacology & physiology.
[15] R. Shoemaker,et al. Novel intrapulmonary model for orthotopic propagation of human lung cancers in athymic nude mice. , 1987, Cancer research.
[16] M. R. Boyd,et al. Biochemical mechanisms in chemical-induced lung injury: roles of metabolic activation. , 1980, Critical reviews in toxicology.
[17] H. Pass,et al. Cellular glutathione and thiol measurements from surgically resected human lung tumor and normal lung tissue. , 1991, Cancer research.
[18] M. J. Coon,et al. Cytochrome P-450 isozymes 2 and 5 in rabbit lung and liver. Comparisons of structure and inducibility. , 1987, Drug metabolism and disposition: the biological fate of chemicals.
[19] M. Boyd,et al. Protective role of endogenous pulmonary glutathione and other sulfhydryl compounds against lung damage by alkylating agents. Investigations with 4-ipomeanol in the rat. , 1982, Biochemical pharmacology.
[20] M. Boyd,et al. The in vitro formation of glutathione conjugates with the microsomally activated pulmonary bronchiolar aklylating agent and cytotoxin, 4-ipomeanol. , 1980, The Journal of pharmacology and experimental therapeutics.
[21] M. Boyd,et al. Species and strain differences in target organ alkylation and toxicity by 4-ipomeanol. Predictive value of covalent binding in studies of target organ toxicities by reactive metabolites. , 1979, Biochemical pharmacology.
[22] M. Boyd,et al. Metabolic activation of 4-ipomeanol by avian tissue microsomes. , 1982, Toxicology and applied pharmacology.
[23] M. Boyd,et al. In vitro studies on the metabolic activation of the pulmonary toxin, 4-ipomeanol, by rat lung and liver microsomes. , 1978, The Journal of pharmacology and experimental therapeutics.
[24] R. Wittes,et al. 4-Ipomeanol: a novel investigational new drug for lung cancer. , 1989, Journal of the National Cancer Institute.
[25] M. Boyd,et al. In vivo studies on the relationship between target organ alkylation and the pulmonary toxicity of a chemically reactive metabolite of 4-ipomeanol. , 1978, The Journal of pharmacology and experimental therapeutics.
[26] M. Boyd,et al. Isolation and characterization of 4-ipomeanol, a lung-toxic furanoterpenoid produced by sweet potatoes (Ipomoea batatas). , 1972, Journal of agricultural and food chemistry.
[27] M. Boyd. Role of metabolic activation in the pathogenesis of chemically induced pulmonary disease: mechanism of action of the lung-toxic furan, 4-ipomeanol. , 1976, Environmental health perspectives.
[28] M. Boyd,et al. Metabolic Basis for the Pulmonary Clara Cell as a Target for Pulmonary Carcinogenesis , 1984, Toxicologic pathology.
[29] M. Boyd. Metabolic activation and lung toxicity: a basis for cell-selective pulmonary damage by foreign chemicals. , 1984, Environmental health perspectives.
[30] M. Boyd,et al. In vivo studies on the target tissue metabolism, covalent binding, glutathione depletion, and toxicity of 4-ipomeanol in birds, species deficient in pulmonary enzymes for metabolic activation. , 1982, Toxicology and applied pharmacology.
[31] M. Boyd,et al. Covalent binding of metabolites of 4-ipomeanol to rabbit pulmonary and hepatic microsomal proteins and to the enzymes of the pulmonary cytochrome P-450-dependent monooxygenase system. , 1983, The Journal of pharmacology and experimental therapeutics.